Clinical trial
Efficacy and Safety of AM-111 in the Treatment of Acute Inner Ear Hearing Loss
NCT02561091 is registered in ClinicalTrials.gov with Auris Medical AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of AM-111 in the Treatment of Acute Inner Ear Hearing Loss
- Lead sponsor
- Auris Medical AG
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- September 30, 2017
- Enrollment
- 256 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.